Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00247819 · ClinicalTrials.gov registry record
The Genetic Basis for Vulnerability to Substance Abuse
A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- 8,000
- Enrollment target
NCT00247819: Completed study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00247819 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 8,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00247819 has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- 8,000 participants
- Enrollment target
Study Summary
This investigation seeks to better define the genetic basis for vulnerability to substance abuse.
Interventions
- PROCEDURE Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,000 participants |
| Start Date | 1992-08 |
| Est. Completion | 2006-02 |
What the finished NCT00247819 record still lists
NCT00247819 is an observational study that tracks outcomes without assigning an intervention. Its 8,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.
NCT00247819 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00247819 about?
NCT00247819 is a clinical study titled "The Genetic Basis for Vulnerability to Substance Abuse". This investigation seeks to better define the genetic basis for vulnerability to substance abuse.
What is the current status of trial NCT00247819?
This trial is currently completed. The enrollment target is 8,000 participants. The study started on 1992-08. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00247819?
The interventions under investigation include: Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT00247819?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
- NCT03072927 · 8,000 participants
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia